Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. - Wikidata - wikimedia - TriplyDB

Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.

Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.

http://www.wikidata.org/entity/Q33375710

about

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Chemosensitized radiosurgery for recurrent brain metastases.Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.Current approaches to the treatment of metastatic brain tumours.Role of palliative radiotherapy in brain metastases.Evolution of multidisciplinary brain metastasis management: case study and literature review Temozolomide for treatment of brain metastases: A review of 21 clinical trials.Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?A systematic approach to the management of patients with brain metastases of known or unknown primary site.Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival.Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.Expression of O⁶-methylguanine DNA methyltransferase (MGMT) and immunohistochemical analysis of 12 pineal parenchymal tumors.Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.

P2860

Q26824799-9768A1E4-4A3B-425D-A3D9-02E858538C33 Q30239901-DA7F39BD-4E3B-4089-9D8E-F38FACA927FD Q33386298-BF863DEF-6DF8-4132-99A1-BD13CB266BBC Q33402904-2F058C40-6A05-4491-B1B8-A3CD59AD62B8 Q33409478-263DEE16-EB1B-4218-AD6D-4BBEB3AB176A Q33430404-6A58B0DE-EC21-44DC-B33B-666661AEBA54 Q33599167-D6FD674D-B414-4336-A7DB-B2D453044C4B Q33696559-6F980F10-1CFC-488B-A1EC-C5D523D5B351 Q33915629-BA2040F9-8A78-43EC-B7E9-4ED4F281B82F Q35652704-EC5F1719-3A6A-4087-B38F-10D0DBE2EE46 Q37576025-DD19F05D-BE9C-4038-ABD1-2A3CA13CEC99 Q37870216-ABD82C81-BE0D-4B62-99A7-9B35391A7CE2 Q37951389-AE2C3E3B-636A-4FD5-8010-653E54E7459B Q38036217-FD997E10-A3FE-45FC-A8F3-DDD21DC8D408 Q38096437-3B0DB57B-7D7A-4E0C-AD4F-8A4696804292 Q38230553-31E06816-263D-42C0-97E3-B31E8B1672CF Q47738880-C5D8E522-7C5D-4876-9BDE-03AE24C9A4BD Q48471112-D31AB480-6B1A-47EB-822D-06C4B58113CB Q48592886-6C519FF2-2FB0-4902-B459-C013D46C973D Q54942365-95DCF832-83BE-49EF-8BB0-1304CDD79276

P2860

Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.

http://www.wikidata.org/entity/Q33375710

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Phase II study of temozolomide ...... metastases from solid tumors.

@ast

Phase II study of temozolomide ...... metastases from solid tumors.

@en

type

label

Phase II study of temozolomide ...... metastases from solid tumors.

@ast

Phase II study of temozolomide ...... metastases from solid tumors.

@en

prefLabel

Phase II study of temozolomide ...... metastases from solid tumors.

@ast

Phase II study of temozolomide ...... metastases from solid tumors.

@en

P1433

Q33375710-344E1C7F-AAE2-42E2-BF31-E433FA30584B

P1476

Q33375710-BA06392B-0452-4F6E-8C04-BFE31BAA127C

P2093

Q33375710-12D8292B-34D5-4E08-9CA0-79E45B20F625

Q33375710-38C82E74-3DCE-43A7-B2E6-B373C09ADB4B

Q33375710-681055AF-5683-411F-83E0-3CD838D6DD17

Q33375710-850714D7-E222-4EDB-8B10-F1F5DA682377

Q33375710-8886680D-AE6D-485B-915F-6A4C78217FAC

Q33375710-ADE2FF4C-FD56-44BA-8C74-2A9086DA3A4D

P2860

Q33375710-23411C3A-618A-45E8-833C-3951C24ED67D

Q33375710-2BD7536D-6F37-41D0-A6AA-73CFFB9E5B2D

Q33375710-35351E46-FD54-4AB9-B600-ED7C21B3F158

Q33375710-3A2CDCF4-EEB4-4122-99CF-A367EE3E4660

Q33375710-46C35AFB-41AA-4CEA-BF64-26360BC26C65

Q33375710-4D1AEB74-070B-4652-8CAC-9FB7D984FEF8

Q33375710-4F49D2DA-D071-4303-ADB1-22F6E50DCD10

Q33375710-61FA3043-A8FF-403C-96E7-8BDB42A554F2

Q33375710-6A54B7A4-CF25-4EF3-A006-F1253FCE5BFE

Q33375710-74ECD056-39ED-497E-AD4F-28F30E68160A

P304

Q33375710-D1BE9B4A-0B6F-4B75-8109-34ADF15AB43D

P31

Q33375710-C603782B-8834-42A4-91D7-BA091AB51C48

P356

Q33375710-B4D141BE-EA66-4959-973F-C9E2294C71E6

P433

Q33375710-B3AD1106-DD2B-4277-A17D-043F2E470B02

P478

Q33375710-F9C5ACA7-F18B-4C53-A049-58A8B503CAA1

P50

Q33375710-FDE0937E-88FF-4A49-B327-CB4A0BC9A6D0

P577

Q33375710-4416328A-DBBB-4045-AF67-67B92489AC5C

P698

Q33375710-85B0F837-BF13-42E9-A8C2-8DE33D93CB44

P921

Q33375710-89CE3278-3F33-409D-BE3C-8A5C49DE869B

P356

P1433

P1476

Phase II study of temozolomide ...... metastases from solid tumors.

@en

P2093

Anthi Miliadou

http://www.w3.org/2001/XMLSchema#string

Dimitrios Kolokouris

http://www.w3.org/2001/XMLSchema#string

John R Kouvaris

http://www.w3.org/2001/XMLSchema#string

Lambros J Vlahos

http://www.w3.org/2001/XMLSchema#string

Myrsini J Balafouta

http://www.w3.org/2001/XMLSchema#string

Xenofon N Papacharalampous

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.

The role of chemotherapy in brain metastases.

Current and future trials of the EORTC brain tumor group.

Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.

Temozolomide in patients with high grade gliomas.

P304

361-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000102557

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Vassilis E Kouloulias

P577

2007-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17596744

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy